Uncategorized Clinical data for oral phage therapy 12 Apr 2023 BiomX Announces Positive Results of a Phase 1a Pharmacokinetic Study for Inflammatory Bowel Disease/Primary Sclerosing Cholangitis (IBD/PSC) Evaluating Delivery of Oral BX002 Phage Therapy BiomX has reported top-line findings from a phase…
PHAGElogist 